A low-cost breast cancer prognosis tool using machine learning
Breast Disease · 2024
DOI: 10.1177/15581551241289699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Disease, 2024. Verfasst von Iván Romarico Gonzalez-Espinoza und 9 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Machine learning (ML) models are cost-effective tools that can establish a prognosis by considering clinical, genomic, and histological data from breast cancer patients. In this study, we evaluate the performance of 12 ML models in predicting the overall survival of breast cancer patients from “The Cancer Genome Atlas-Breast Cancer” database at 60 months of follow-up. The models evaluated were Logistic Regression (LR), Ridge Classifier (RC), Least Absolute Shrinkage and Selection Operator (LASSO), K-Nearest Neighbors (KNN), Naive Bayes (NB), Linear Discriminant Analysis (LDA), Decision Tree (DT), Multilayer Perceptron (MP), Stochastic Gradient Descent (SGD), Support Vector Machine (SVM), Random Forest (RF), and XGBoost (XGB). The most accurate models were NB (86.76%) and SGD (85.29%). The models with the highest sensitivity were SGD (93.75%), MP (91.67%), and NB (89.89%), while the models with the highest specificity were KNN (95.0%), DT (90.0%), and LASSO (85.0%). The models with the highest area under the ROC curve were LDA (90.83%), LASSO (90.1%), and LR (89.79%). The most relevant variables were “Previous Diagnosis of Cancer,” “Presence of Tumor,” “Ancillary Therapy,” and “Histology.” Our findings demonstrate that AI tools for predicting patient outcomes are a viable option when expensive prognostic genomic tools are not available. According to our results, NB and LASSO show promising performance in predicting the prognosis of breast cancer patients. Further studies with data from developing countries are needed to improve the performance of these tools.
Zitieren
APA
Gonzalez-Espinoza, I. R., Castro-Ponce, A., Castelló-Pons, M., Jímenez-Monferrer, S., Cardona-Ferrer, E., Juárez-Salazar, G., Juárez-Salazar, D. A., Chiquillo-Domínguez, M., Miguel-Cruz, E., & González-Lozada, L. E. (2024). A low-cost breast cancer prognosis tool using machine learning. Breast Disease. https://doi.org/10.1177/15581551241289699
Vancouver
Gonzalez-Espinoza IR, Castro-Ponce A, Castelló-Pons M, Jímenez-Monferrer S, Cardona-Ferrer E, Juárez-Salazar G, et al. A low-cost breast cancer prognosis tool using machine learning. Breast Disease. 2024. doi:10.1177/15581551241289699
BibTeX
@article{GonzalezEspinoza2024,
author = {Gonzalez-Espinoza, Iván Romarico and Castro-Ponce, Abraham and Castelló-Pons, María and Jímenez-Monferrer, Sergio and Cardona-Ferrer, Edgar and Juárez-Salazar, Gabriela and Juárez-Salazar, Diego A and Chiquillo-Domínguez, Mariana and Miguel-Cruz, Enrique and González-Lozada, Laura E},
title = {A low-cost breast cancer prognosis tool using machine learning},
journal = {Breast Disease},
year = {2024},
doi = {10.1177/15581551241289699}
}
EUVIMED